[Federal Register Volume 67, Number 60 (Thursday, March 28, 2002)]
[Corrections]
[Page 15011]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C2-6767]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Agency
21 CFR Part 1308
[DEA-225P]
Schedule of Controlled Substances: Proposed Rule: Rescheduling of
Buprenorphine From Schedule V to Schedule III
Correction
In proposed rule document 02-6767 beginning on page 13114 in the
issue of Thursday, March 21, 2002, make the following corrections:
1. On page 1135, in the first column, in the second paragraph, in
the first line, ``(0.3mg/m1)'' should read, ``(0.3mg/ml)''.
2. On the same page, in the first column, in the second paragraph,
in the fifth line, ``Subozone'' should read,
``Suboxone''.
3. On the same page, in the second column, in the second paragraph,
in the thirteenth line, ``table'' should read, ``tablet''.
4. On the same page, in the same column, in the second paragraph,
in the 15th line, ``fewer'' should read, ``newer''.
5. On page 13115, under the heading ``What Is the Effect of This
Notice?'', in the first paragraph, in the fourth line, ``salts or ''
should read, `` salts of''.
[FR Doc. C2-6767 Filed 3-27-02; 8:45 am]
BILLING CODE 1505-01-D
